NO872115L - Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider. - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider.

Info

Publication number
NO872115L
NO872115L NO87872115A NO872115A NO872115L NO 872115 L NO872115 L NO 872115L NO 87872115 A NO87872115 A NO 87872115A NO 872115 A NO872115 A NO 872115A NO 872115 L NO872115 L NO 872115L
Authority
NO
Norway
Prior art keywords
preparation
agent
pharmacologically active
compound
formula
Prior art date
Application number
NO87872115A
Other languages
English (en)
Other versions
NO173278B (no
NO173278C (no
NO872115D0 (no
Inventor
Arthur G Schwartz
Marvin Louis Lewbart
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of NO872115D0 publication Critical patent/NO872115D0/no
Publication of NO872115L publication Critical patent/NO872115L/no
Publication of NO173278B publication Critical patent/NO173278B/no
Publication of NO173278C publication Critical patent/NO173278C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO872115A 1986-05-21 1987-05-20 Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater NO173278C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86711286A 1986-05-21 1986-05-21

Publications (4)

Publication Number Publication Date
NO872115D0 NO872115D0 (no) 1987-05-20
NO872115L true NO872115L (no) 1987-11-23
NO173278B NO173278B (no) 1993-08-16
NO173278C NO173278C (no) 1993-12-01

Family

ID=25349110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872115A NO173278C (no) 1986-05-21 1987-05-20 Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater

Country Status (12)

Country Link
EP (1) EP0246650B1 (no)
JP (1) JP2566574B2 (no)
AT (1) ATE71107T1 (no)
AU (1) AU601184B2 (no)
CA (1) CA1329195C (no)
DE (1) DE3775617D1 (no)
DK (1) DK173168B1 (no)
ES (1) ES2039373T3 (no)
GR (1) GR3003769T3 (no)
IE (1) IE60027B1 (no)
NO (1) NO173278C (no)
PT (1) PT84911B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424463A (en) * 1990-08-29 1995-06-13 Humanetics Corporation Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
JP2973031B2 (ja) * 1990-08-29 1999-11-08 ヒューマネティックス コーポレーション 減量を促進するための置換δ５−アントロステンを含む医薬
US5585371A (en) * 1990-08-29 1996-12-17 Humanetics Corporation Treatment of immune system with Δ5-androstenes
JPH0684398B2 (ja) * 1990-08-31 1994-10-26 雪印乳業株式会社 新規なアンドロステン誘導体及びそれを用いる６‐アルキルカルボニルオキシ‐１４α‐ヒドロキシ‐アンドロスト‐４，６‐ジエン‐３，１７‐ジオンの製造法
AU2002211563A1 (en) * 2000-10-06 2002-04-15 Aeson Therapeutics Inc. Compounds useful for treating hypertriglyceridemia
WO2003092722A1 (en) * 2002-05-01 2003-11-13 Arthur Schwartz 7-HYDROXY-16α-FLUORO-5-ANDROSTEN-17-ONES AND 7-HYDROXY-16α-FLUORO-5-ANDROSTAN-17-ONES AND DERIVATIVES THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK375384A (da) * 1983-08-02 1985-02-03 Research Corp Steroider, der er anvendelige som midler mod cancer, obesitet, hyperglykaemi, autoimmunitet og hypercholesterolaemi
IE58540B1 (en) * 1985-08-02 1993-10-06 Research Corp Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
JP2920854B2 (ja) * 1991-08-01 1999-07-19 富士通株式会社 ビィアホール構造及びその形成方法

Also Published As

Publication number Publication date
EP0246650B1 (en) 1992-01-02
DK173168B1 (da) 2000-02-28
DE3775617D1 (de) 1992-02-13
NO173278B (no) 1993-08-16
PT84911B (pt) 1990-02-08
JPS62283993A (ja) 1987-12-09
DK259387D0 (da) 1987-05-21
JP2566574B2 (ja) 1996-12-25
ES2039373T3 (es) 1993-10-01
NO173278C (no) 1993-12-01
GR3003769T3 (no) 1993-03-16
DK259387A (da) 1987-11-22
IE871312L (en) 1987-11-21
ATE71107T1 (de) 1992-01-15
CA1329195C (en) 1994-05-03
AU7329687A (en) 1987-11-26
PT84911A (en) 1987-06-01
IE60027B1 (en) 1994-05-18
AU601184B2 (en) 1990-09-06
NO872115D0 (no) 1987-05-20
EP0246650A1 (en) 1987-11-25

Similar Documents

Publication Publication Date Title
AU595192B2 (en) Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions
CA2124932A1 (en) Sex steroid activity inhibitors
IE881269L (en) Steroids
IE940525L (en) Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
AU4703989A (en) Phosphinic acid substituted steroids as inhibitors of 5 alpha-reductase
ATE116657T1 (de) 7-keto- und 7-hydroxy-androsta-3,5-dien-3- carbonsäure derivate.
GEP20012389B (en) Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia
NO872115D0 (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider.
NO158379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroalifatiske forbindelser.
AU6216886A (en) Substituted 2-cyano-2-phenyl ethyl-amine
JPS5549316A (en) Lysosomotropic therapy
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
NZ233704A (en) Dehydrocholecalciferol derivatives, pharmaceutical compositions thereof
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
NO172541C (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
EP0414530A3 (en) 3-substituted steroid derivatives
ES8503247A1 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
AU2013888A (en) Uricosuric composition
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees